Clinical trial
Insulin Resistance and Vessel Function After Meals: Does Early Intervention Make…
NCT00259168 · Atheline Major-Pedersen, Other · Completed
Key facts
| NCT number | NCT00259168 |
|---|---|
| Title | Insulin Resistance and Vessel Function After Meals: Does Early Intervention Make a Difference? |
| Official title | Insulin Resistance and Postprandial Endothelial Function: Does Early Intervention Make a Difference? |
| Lead sponsor | Atheline Major-Pedersen, Other |
| Collaborators | Novartis Industry Bayer |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Insulin Resistance, Impaired Fasting Glucose |
| Intervention type | Drug |
| Interventions | Nateglinide |
| Enrollment | 70 |
| Start date | Jun 1, 2003 |
| Primary completion | Mar 1, 2006 |
| Completion | Mar 1, 2006 |
| First posted | Nov 29, 2005 |
| Last update posted | Dec 3, 2018 |
| Countries | Denmark |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: